Criticism of the Pharma Cartel and Its ‘Business With Disease’ Is Becoming Mainstream

Authored by Dutch political scientist Joost Smiers, the NRC article describes how society is now at the mercy of the pharma business and its shareholders. “As far as I am concerned,” Smiers writes, “it is high time to break the societal feeling of powerless towards Big Pharma.”

April 1, 2023 | Source: GlobalResearch | by Paul Anthony Taylor

Making pharma obsolete

Pointing out that research into medicines can be done separate from the pharma industry, at universities and other independent research institutes, Smiers argues that substantial research funds should be established, fed from public funds, with independent committees deciding which diseases and researchers funding should be directed towards. Smiers stresses the importance of these committees functioning at arm’s length from governments. Crucially, he also proposes that alternative health therapies such as vitamins could benefit from this approach.

The Omicron Variant: Deliberately Raising the Global State of Panic

Just as importantly, Smiers stresses that all knowledge resulting from medicines research should be publicly and freely available. Mirroring the long-time position held by Dr. Rath and our Foundation, he adds that there should be no more patents involved – thus avoiding the present situation whereby patent owners have a monopoly on the use, or non-use, of scientific knowledge.